Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cardiovascular Lipids / Lipoproteins Fatty Acids Synthesis

Anti-ACOT12 antibody (ab196783)

Anti-ACOT12 antibody (ab196783)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to ACOT12
  • Suitable for: IHC-P, ICC/IF
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Anti-Acetyl Coenzyme A Carboxylase antibody [EPR4971] - BSA and Azide free (ab231681)
Product image
Anti-Fatty Acid Synthase antibody - BSA and Azide free (ab281555)
Product image
Recombinant Human TERP protein (ab113128)
Product image
Anti-Acetyl Coenzyme A Carboxylase (phospho S80) antibody (ab53688)

Overview

  • Product name

    Anti-ACOT12 antibody
  • Description

    Rabbit polyclonal to ACOT12
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    IHC-P
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human ACOT12 (internal sequence).
    Database link: Q8WYK0

  • Positive control

    • Human liver carcinoma tissue; A549 cells.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituents: 49% PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride

    PBS without Mg2+ and Ca2+.
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Purification notes

    ab196783 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Cardiovascular
    • Lipids / Lipoproteins
    • Fatty Acids
    • Synthesis
    • Signal Transduction
    • Metabolism
    • Lipid metabolism
    • Cardiovascular
    • Lipids / Lipoproteins
    • Fatty Acids
    • Metabolism
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Lipid and lipoprotein metabolism
    • Fatty acids
    • Metabolism
    • Pathways and Processes
    • Redox metabolism
    • Fatty acid oxidation

Images

  • Immunocytochemistry/ Immunofluorescence - Anti-ACOT12 antibody (ab196783)
    Immunocytochemistry/ Immunofluorescence - Anti-ACOT12 antibody (ab196783)

    Immunofluorescent analysis of A549 cells labeling ACOT12 with ab196783 at 1/100 dilution, in the presence (right panel) or absence (left panel) of immunizing peptide.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACOT12 antibody (ab196783)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACOT12 antibody (ab196783)

    Immunohistochemical analysis of paraffin-embedded Human  liver carcinoma tissue labeling ACOT12 with ab196783 at 1/50 dilution, in the presence (right panel) or absence (left panel) of immunizing peptide.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.